Innovative treatment of internal tumours, using electroporation. Currently in clinical trials treating colorectal cancer.
MitaMed has commenced clinical trials for its ground breaking treatment for gastrointestinal and lung cancers. Current Standards of Care have low success rates, severe impact on Quality of Life and are expensive. MitaMed’s solution addresses these shortcomings. Over 1.3MM people are diagnosed with colorectal, oesophageal or lung cancer in EU/US per year and would benefit from our minimally invasive, out-patient treatment, with lower side effects.